Last reviewed · How we verify
standard pain relievers
Standard pain relievers work by inhibiting cyclooxygenase (COX) enzymes or blocking pain signal transmission to reduce pain perception.
Standard pain relievers work by inhibiting cyclooxygenase (COX) enzymes or blocking pain signal transmission to reduce pain perception. Used for Mild to moderate pain, Fever, Inflammation-related pain conditions.
At a glance
| Generic name | standard pain relievers |
|---|---|
| Also known as | Standard pain relievers in accordance with the current practice |
| Sponsor | GCS Ramsay Santé pour l'Enseignement et la Recherche |
| Drug class | Nonsteroidal anti-inflammatory drug (NSAID) or analgesic |
| Target | COX-1 and/or COX-2 enzymes (for NSAIDs); central pain pathways (for acetaminophen) |
| Modality | Small molecule |
| Therapeutic area | Pain Management |
| Phase | FDA-approved |
Mechanism of action
Most standard pain relievers fall into two main categories: nonsteroidal anti-inflammatory drugs (NSAIDs) that inhibit COX-1 and COX-2 enzymes to reduce prostaglandin production, thereby decreasing inflammation and pain; and acetaminophen, which works through central nervous system pathways to reduce pain perception and fever. These mechanisms provide analgesia across a range of mild to moderate pain conditions.
Approved indications
- Mild to moderate pain
- Fever
- Inflammation-related pain conditions
Common side effects
- Gastrointestinal upset
- Nausea
- Headache
- Dizziness
- Hepatotoxicity (acetaminophen at high doses)
Key clinical trials
- Examining Analgesic Synergy and Efficacy in Trauma Care (PHASE4)
- Induction of Labor by Cervical Ripening and Transcutaneous Electrical Nerve Stimulation (TENS) (NA)
- A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103) (PHASE3)
- Ultrasound-Guided Serratus Posterior Superior Intercostal Plane Block for Analgesia in Arthroscopic Shoulder Surgery (NA)
- Comparison of Two Intravenous Drug Combinations for Ambulatory Oral & Maxillofacial Surgery (PHASE1)
- Regenerative Collagen Scaffold for Breast Volume Restoration After Breast Cancer Excision (NA)
- Bilateral Cervical Plexus Block for Postoperative Pain After Thyroidectomy (NA)
- A Clinical Trial of Sac-TMT in People With Non-HRD Positive Advanced Ovarian Cancer (MK-2870-021) (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- standard pain relievers CI brief — competitive landscape report
- standard pain relievers updates RSS · CI watch RSS
- GCS Ramsay Santé pour l'Enseignement et la Recherche portfolio CI